A study to investigate the effect of lepodisiran on the reduction of major adverse cardiovascular events in adults with elevated lipoprotein(a) (ACCLAIM-Lp(a)) (NCT06292013)
Please login or create a FREE account to view this content
Educational Partners and Supporters
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.(Founding Partner)